logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
G

Giannis Mountzios

henry dunant hospital center
H指数:40
被引数:6,327

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extended follow-up of tarlatamab in patients with small-cell lung cancer after platinum-based chemotherapy in the randomized phase 3 DeLLphi-304 study

在随机III期DeLLphi-304研究中，铂类化疗后小细胞肺癌患者接受tarlatamab的延长随访

Annals of Oncology
IF65.4
2026-10-260
OAAI
C.M. Rudin; M-J. Ahn; M. Schuler; F.H. Blackhall; G. Mountzios; T. Yoshida; L. Sun; B.C. Cho; A. Lugini; S. Arulananda; S.R. Punekar; P. Rocha; L. Paz-Ares; J. Mazières; M. Gümüş; U. Demirci; S. Huang; B. Abidi; U. Patil; B. Zhu
Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial

在铂类化疗后广泛期小细胞肺癌中使用塔拉他玛单抗的病人报告结局：DeLLphi-304 III期试验结果

Lung Cancer
IF4.4
2026-09-010
PRE
Mountzios, Giannis; Lammers, Philip E.; Sun, Longhua; Cho, Byoung Chul; Demirci, Umut; Arulananda, Surein; Gumus, Mahmut; Punekar, Salman; Lugini, Antonio; Zhu, Bo; Yu, Yan; Ciuleanu, Tudor-Eliade; Ahn, Myung-Ju; Mazieres, Julien; Schuler, Martin; Blackhall, Fiona; Yoshida, Tatsuya; Dirnberger, Franziska; Wang, Jessie; Huang, Shuang; Gauto, Diana; Rudin, Charles M.
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation

抗体药物偶联物在特定实体瘤中的应用：基于ETOP IBCSG Partners基金会第三次研讨会成果的立场声明更新

ESMO Open
IF8.3
2026-07-010
OAAI
Peters, S.; Meyer, M. -l.; Andre, F.; Argiles, G.; Azizi, A. A.; Banerjee, S.; Burgers, S.; Curigliano, G.; Drago, J. Z.; Fontana, E.; Garon, E. B.; Klumper, N.; Le Bescond, L.; Lopez-Rios, F.; Mountzios, G.; Passaro, A.; Paz-Ares, L.; Pistilli, B.; Powles, T.; Reguart, N.; Remon, J.; Schmelzle, T.; Skynner, M. J.; Smit, E.; Smyth, E.; Swanton, C.; Van Cutsem, E.; Loi, S.; Stahel, R. A.
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors

ESMO-ESTRO关于将放射治疗与EGFR、ALK或BRAF/MEK抑制剂联合使用的安全性共识声明

ESMO Open
IF8.3
2026-02-260
OAAI
E.S.M. van Aken; S.M. O’Cathail; A.K. Gandhi; J. Bussink; L. Castelo-Branco; J.G. Eriksen; G. Argilés; C.T. Hiley; V. Atkinson; J. Kaźmierska; A. Calles; K. Konopa; E. Le Rhun; F. McDonald; G. Mountzios; P.M. Putora; B. Muoio; U. Ricardi; C.B. Westphalen; A. Wrona
Understanding Exceptional Response: The Role of MINDY1 SNP in CDK4/6 Inhibitor Therapy for ER-Positive, HER2-Negative Advanced Breast Cancer

理解超常反应：MINDY1 SNP在ER阳性、HER2阴性晚期乳腺癌CDK4/6抑制剂疗法中的作用

Human Genetics and Genomics Advances
IF3.6
2025-12-240
OAAI
Eleni Balla; Yi Li; Zikun Zhou; John T. Nguyen; Kyriaki Papadopoulou; Evangelia Razis; Angelos Koutras; Eleni Galani; Giannis Mountzios; Ourania Romanidou; George Fountzilas; Athina Christopoulou; Dimitris Tryfonopoulos; Panagiota Oikonomopoulou; Zenia Saridaki; Anna Koumarianou; Elena Fountzilas; Leonidas Bleris
Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece—The TRINITY Study

真实世界中希腊早期或局部晚期三阴性乳腺癌患者新辅助全身治疗的应用及治疗模式—TRINITY研究

Cancers 2025, Vol. 17, Page 4023
IF4.4
2025-12-170
OAAI
Konstantinos Papazisis; Christos Christodoulou; Flora Zagouri; Ippokratis Korantzis; Ioannis Boukovinas; Anna Koumarianou; Angelos Koutras; Eleni Timotheadou; Giannis Mountzios; Loukas Kontovinis; Ioannis Binas; Alkistis Papatheodoridi; Eleni Zairi; Ilias Gountas; Danai Ktena; Charalampos Athanasopoulos; Athanasios Kotsakis; Emmanouil Saloustros
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中，具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局：基于Transformer的AI用于表征预后复杂性

Lung Cancer
IF4.4
2025-10-160
OAAI
Alessio Cortellini; Edoardo Garbo; Giulia La Cava; Fabrizio Citarella; Valentina Santo; Leonardo Brunetti; David J Pinato; Jarushka Naidoo; Monica Loza; Carlo Genova; Scott Gettinger; So Yeon Kim; Ritujith Jayakrishnan; Talal El Zarif; Marco Russano; Federica Pecci; Alessandro Di Federico; Michele Montrone; Dwight H Owen; Diego Signorelli; Mingjia Li; Andrea Camerini; Balazs Halmos; Bruno Vincenzi; Giulio Metro; Sai Yendamuri; Francesco Grossi; Eleni Josephides; Bartłomiej Tomasik; Raffaele Giusti; Emilio Bria; Martin Sebastian; Maximilian Rost; Fabian Acker; Lorenza Landi; Francesca Mazzoni; Alessandro Morabito; Alessandro Leonetti; Luca Cantini; Giannis Mountzios; Sukumar Kalvapudi; David O’Reilly; Eleni Karapanagiotou; Isabelle Monnet; Javier Baena; Marianna Macerelli; Margarita Majem; Aida Piedra; Diego L Cortinovis; Giuseppe Tonini; Gabriele Minuti; Laura Mezquita; Teresa Gorria; Teresa Beninato; Giuseppe Lo Russo; Arsela PrelaJ; Andrea De Giglio; Federica Biello; Frank Aboubakar Nana; Anne-Marie C. Dingemans; Joachim GJV Aerts; Roberto Ferrara; Taher Abu Hejleh; Kazuki Takada; Abdul R Naqash; Marina C Garassino; Heather A. Wakelee; Amin Nassar; Biagio Ricciuti; Paolo Soda; Camillo Maria Caruso; Valerio Guarrasi
Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final Outcome, Immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group study.

插入式阿维鲁唑胺联合铂类为基础的化疗在广泛期小细胞肺癌患者中的应用（PAVE）：一项多中心Hellenic Cooperative Oncology Group II期研究的最终结果、免疫表型分析和生物标志物分析。

European Journal of Cancer
IF7.1
2025-07-250
OAAI
Helena Linardou; Kyriaki Papadopoulou; Nikolaos Korfiatis; Anna Goussia; Epaminondas Samantas; Gerasimos Aravantinos; Athina Christopoulou; Nikolaos Spathas; Elena Fountzilas; Amanda Psyrri; Georgia-Angeliki Koliou; Soultana Meditskou; Epaminondas Kosmas; Mattheos Bobos; Antonia V. Charchanti; Ioannis Vamvakaris; Anna Koumarianou; Dimitrios Bafaloukos; Paris Kosmidis; George Fountzilas; Giannis Mountzios
Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary
FUTURE ONCOLOGY
IF2.6
2025-03-010
OAAI
de Langen, Adrianus Johannes; Johnson, Melissa L.; Mazieres, Julien; Dingemans, Anne-Marie C.; Mountzios, Giannis; Pless, Miklos; Wolf, Juergen; Schuler, Martin; Lena, Herve; Skoulidis, Ferdinandos; Yoneshima, Yasuto; Kim, Sang-We; Linardou, Helena; Novello, Silvia; van der Wekken, Anthonie J.; Chen, Yuanbin; Peters, Solange; Felip, Enriqueta; Solomon, Benjamin J.; Ramalingam, Suresh S.; Dooms, Christophe; Lindsay, Colin R.; Ferreira, Carlos Gil; Blais, Normand; Obiozor, Cynthia C.; Wang, Yang; Mehta, Bhakti; Varrieur, Tracy; Ngarmchamnanrith, Gataree; Stollenwerk, Bjoern; Waterhouse, David; Paz-Ares, Luis
Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study
FUTURE ONCOLOGY
IF2.6
2025-01-090
PRE
Mountzios, Giannis; Lampaki, Sofia; Linardou, Helena; Georgoulias, Vassilis; Mavroudis, Dimitrios; Anevlavis, Stavros; Charpidou, Andriani; Lykka, Maria; Spyratos, Dionysis; Sarris, Evangelos G.; Somarakis, Alvertos; Papista, Christina; Glentis, Alexandros; Nikolaou, Aristeidis; Paparepa, Zoe; Papageorgiou, Foteini; Syrigos, Konstantinos N.
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLC

Sotorasib (960 mg或240 mg) 每天一次用于先前接受过KRAS治疗的晚期NSCLC患者G12C-mutated

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-09-012
PRE
Hochmair, Maximilian J.; Vermaelen, Karim; Mountzios, Giannis; Carcereny, Enric; Dooms, Christophe; Lee, Se-Hoon; Morocz, Eva; Kato, Terufumi; Ciuleanu, Tudor-Eliade; Dy, Grace K.; Parente, Barbara; O'Byrne, Kenneth J.; Chu, Quincy S.; De Castro Junior, Gilberto; Girard, Nicolas; Snyder, Wendy; Tran, Qui; Kormany, William; Houk, Brett; Mehta, Bhakti; Curioni-Fontecedro, Alessandra
Clinical features of progression and outcomes with subsequent therapies in patients treated with RET-inhibitors
MOLECULAR CANCER THERAPEUTICS
IF5.5
2023-12-010
PRE
Marinello, Arianna; Zrafi, Wael Salem; Massa, Giacomo; Tabbo, Fabrizio; Citarella, Fabrizio; Dall'Olio, Filippo Gustavo; Colin, Lindsay; Bria, Emilio; Metro, Giulio; Minatta, Jose Nicolas; Calles, Antonio; Monnet, Isabelle; Tagliamento, Marco; De Saint Basile, Hortense Gaultier; Girard, Nicolas; Pagliaro, Arianna; Cortinovis, Diego Luigi; Raimbourg, Judith; Zanchetta, Carol; Mountzios, Giannis; Nana, Frank Aboubakar; Terrisse, Safae; Russo, Alessandro; Iranzo, Patricia; Audigier-Valette, Clarisse; Rochigneux, Philippe; Fallet, Vincent; Duruisseaux, Michael; Cousin, Sophie; Guisier, Florian; Mezquita, Laura; Remon, Jordi; Gazzah, Anas; Planchard, David; Besse, Benjamin; Aldea, Mihaela
Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group (HeCOG) study: Interim analysis

晚期非小细胞肺癌患者数字支持的临床和分子研究: snf-climedin，一项前瞻性随机希腊肿瘤协作组 (HeCOG) 研究: 中期分析

ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Linardou, H.; Kosmidis, T.; Papadopoulou, K.; Korfiatis, N.; Lampaki, S.; Fountzilas, E.; Psyrri, A.; Vagionas, A.; Christopoulou, A. N.; Samantas, E.; Athanasiadis, I.; Mountzios, G.; Tsoukalas, N. G.; Sgouros, J. I.; Koutras, A.; Bafaloukos, D.; Panopoulos, C. G.; Fountzilas, G.; Kosmidis, P. A.

研究方向

暂未获取到该数据
H
Helena Linardou
H 指数:37论文数:217被引数:8,731
A
Athina Christopoulou
H 指数:17论文数:132被引数:1,400
M
Meletios Α. Dimopoulos
H 指数:159论文数:3,004被引数:12.8万
C
Christos Papadimitriou
H 指数:48论文数:421被引数:1.0万
E
Emmanouil Saloustros
H 指数:41论文数:241被引数:9,560
A
Amanda Psyrri
H 指数:58论文数:603被引数:1.8万
P
P. Kosmidis
H 指数:48论文数:429被引数:9,524
E
Elena Fountzilas
H 指数:24论文数:156被引数:3,087
P
Panagiota Economopoulou
H 指数:0论文数:1被引数:14
A
Anna Koumarianou
H 指数:30论文数:246被引数:3,007